National Cancer Center Inc

National Cancer Center Inc shows consistent revenue growth and asset accumulation with no reported officer compensation.

EIN: 131919715 · West Islip, NY · NTEE: G30Z · Updated: 2026-03-28

$3.6MRevenue
$1.9MAssets
75/100Mission Score (Good)
G30Z

Resolve This Donation Decision

Should someone trust, compare, or avoid National Cancer Center Inc?

This page is being rebuilt as a decision workflow: verify the public record, understand where money goes, compare better nearby or category peers, then save the evidence into a report or watchlist when the decision matters.

Source Check Matrix

What Has Been Verified vs. What Needs Human Review

Identity resolved verified

National Cancer Center Inc is mapped to EIN 131919715.

IRS BMF exempt record needs review

Open IRS TEOS or BMF source before relying on exemption status.

IRS Pub 78 deductibility needs review

Pub 78 eligibility should be verified in IRS TEOS before money changes hands.

IRS automatic revocation needs review

Check the official auto-revocation bulk source or cached evidence before relying on current exemption.

IRS Form 990 index verified

13 stored filing years available.

Raw 990 source linked

Open ProPublica to verify the raw filing record and PDFs.

Filing depth verified

13 stored filing years available.

State charity registration manual confirmation

Open New York charities registry; the workflow stops for human confirmation unless a stable source is cached.

Candid / GuideStar profile api pending

Candid API access is not configured; open manually and do not count as verified evidence.

Charity Navigator rating api pending

Charity Navigator API access is not configured; open manually and do not count as verified evidence.

Source and Resolution Links

Finish the Investigation Outside Our Dataset

When the answer lives with the IRS, ProPublica, Candid, Charity Navigator, or the nonprofit itself, NonprofitSpending links out instead of trapping the user on a partial answer.

IRS tax-exempt lookup

Verify exemption status and deductibility directly with the IRS.

IRS bulk evidence downloads

Check Pub 78, automatic revocation, 990-N, and Form 990 bulk evidence sources.

IRS EO BMF extract

Open the official Business Master File extract source for tax-exempt organization records.

ProPublica 990 source

Open the raw filing record and filing PDFs outside NonprofitSpending.

New York charities registry

Confirm state charity registration or solicitation status where applicable.

Candid profile search

Look for GuideStar/Candid profile details, programs, leadership, and seals.

Charity Navigator search

Check whether another evaluator has ratings or impact context.

Workflow Engine

Queries We Should Resolve, Not Just Answer

Search Console demand points to task completion. Each workflow can run calculations, source checks, external lookups, comparisons, and report/export capture around this nonprofit.

Verify tax status Runnable

Triggered by: 501(c)(3), tax deductible, EIN

IRS status check plus source links

Verify official evidence Runnable

Triggered by: IRS Pub 78, BMF, revocation, 990 index, state registration

Official-source evidence matrix with human stops where a state portal must be checked.

Find source filings Runnable

Triggered by: 990 PDF, annual report, filing record

13 stored filing years plus ProPublica source

Crunch money signals Runnable

Triggered by: program expense ratio, CEO salary, revenue, grants

75% program spend, health grade A

Compare alternatives Runnable

Triggered by: best charities, similar nonprofits, compare

4 peer options surfaced

Resolve leadership and board Runnable

Triggered by: executive team, trustees, officer pay

Use 990 compensation disclosures and external profile links.

Donation decision copilot Runnable

Triggered by: should I donate, give or compare, charity safety

Eligibility, money signals, sources, peer context, and next action.

Grantmaker due diligence Runnable

Triggered by: foundation review, grant risk, grantee capacity

Foundation-style packet across filings, finances, governance, and gaps.

Impact evidence finder Runnable

Triggered by: outcomes, annual report, cost effectiveness

Separate actual impact evidence from raw 990 financial cleanliness.

Room for more funding Runnable

Triggered by: would my donation help, funding gap, marginal impact

Revenue trend, runway, surplus/deficit, and source follow-ups.

Operator transparency diagnostic Runnable

Triggered by: how does my nonprofit look to donors

Profile, filing, impact, and transparency improvements to earn trust.

National Cancer Center Inc Financial Summary
MetricValue
Total Revenue$3.6M
Total Expenses$4.5M
Program Spending75%
CEO/Top Officer Pay$3
Net Assets$2.8M
Transparency Score75/100

Search Intent Cockpit

National Cancer Center Inc Form 990, Revenue, CEO Pay, and IRS Filing Signals

National Cancer Center Inc is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around National Cancer Center Inc in one place.

Form 990 Filing Summary

13 filing years are available, with latest revenue of $4.6M and expenses of $4.5M.

Revenue and Expenses

National Cancer Center Inc reported $4.6M in revenue and $4.5M in expenses, a surplus of $27K.

Executive Compensation

Top officer compensation appears as $3 in the stored analysis, with context against revenue and expenses below.

Charity Score and Red Flags

75/100 mission score, 2 red flags, and 3 strengths are shown from structured and AI review.

Is National Cancer Center Inc Legit?

Some Concerns

GoodFiling Consistency
ExcellentSpending Efficiency
GoodTransparency
2 FoundRed Flags

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

IRS 990 Data Cockpit

Where the Money Comes From and Where It Goes

PendingDonor/Grant Funding
75%Program Expense
$0Grants Paid
13Stored Filing Years

Revenue Source Mix

Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.

Expense Deployment

National Cancer Center Inc Expense Deployment
Program services$3.4M (75%)

Across stored filings, National Cancer Center Inc shows contribution history pending. Next enrichment targets: revenue-source fields, IRS BMF classification.

Decision Cockpit

One-Stop Donor, Research, and Peer Context Hub

National Cancer Center Inc Donor Decision Matrix
Decision LensSignalWhat to Inspect Next
LegitimacySome ConcernsGood filing record; 2 red flags identified
Mission spend75% to programsExcellent
Financial durabilityGrade A13 stored filing years
Peer contextCompare with Healthy Capital District InitiativeNew York and Category G context

Trust Check

Review legitimacy, deductibility, red flags, and filing consistency.

Open charity check →

Peer Benchmark

Compare against real state and category peers.

Compare with Healthy Capital District Initiative →
All New York nonprofits
All Category G

Local and Sector Spokes

Move into this nonprofit's local market, category, and sector maps.

West Islip, NY nonprofits
Category G in New York
Health in New York

Follow the Money

Jump into spending, compensation, rankings, and filing-year evidence.

State spending analysis
State compensation analysis
Category G spending
Best Category G charities in New York
Relevant rankings

Donation Decision Flow

From Trust Check to Better Alternatives

1

Verify

Some Concerns. Check deductibility, filings, and red flags.

2

Understand money

75% of spending goes to programs.

3

Compare

Benchmark against Healthy Capital District Initiative.

4

Decide

Build a shortlist, compare alternatives, and review the latest filing before giving.

Alternative Shopping

Similar Nonprofits Donors Should Compare

Browse the full Category G peer market in New York →

Next Best Actions

Keep the Investigation Moving

Verify legitimacy

Open the focused charity-check flow before donating.

Compare a peer

Benchmark against Healthy Capital District Initiative.

Find best peers

See best Category G charities in New York.

Inspect local compensation

See whether pay levels look unusual in this state.

Research Workflow

Turn this Form 990 profile into a donor-ready report

Request a concise report for National Cancer Center Inc with revenue, expenses, executive compensation, red flags, peer context, and IRS source links. You can also request CSV exports or watchlist updates for future filings.

Get spending reportDonor-ready PDF summary.
Request CSV exportFiling-year data for research.
Watch this nonprofitUpdates when public data changes.

Early access request only. Reports and exports are informational and based on public IRS records, not financial or legal advice.

National Cancer Center Inc directs 75% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.

About National Cancer Center Inc

National Cancer Center Inc (EIN: 131919715) is a nonprofit organization based in West Islip, NY, classified under NTEE code G30Z. The organization reported total revenue of $3.6M and total assets of $1.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of National Cancer Center Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

73Years Operating
Mid-SizeSize Classification
13Years of Filings
MixedRevenue Trajectory

National Cancer Center Inc is a mid-size nonprofit that has been operating for 73 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 6.8%.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

Total Revenue$4.6M
Total Expenses$4.5M
Surplus / Deficit+$27K
Total Assets$3.8M
Total Liabilities$1.1M
Net Assets$2.8M
Operating Margin0.6%
Debt-to-Asset Ratio28.0%
Months of Reserves10.2 months

Financial Health Grade: A

In 2023, National Cancer Center Inc reported a surplus of $27K with revenue exceeding expenses, holds 10.2 months of operating reserves (strong position), has a debt-to-asset ratio of 28.0% (moderate leverage).

Financial Trends

Over 13 years of filings (2011–2023), National Cancer Center Inc's revenue has grown at a compound annual growth rate (CAGR) of 6.8%.

YearRevenue ChangeExpense ChangeAsset Change
2023-0.5%+1.3%+1.5%
2022-20.0%-7.2%-4.6%
2021+20.7%+14.0%+41.0%
2020+14.1%+17.4%+30.7%
2019+27.0%+12.7%+26.6%

IRS Tax-Exempt Classification

IRS Classification Codes8000
IRS Ruling Date1953

Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.

AI Transparency Report

National Cancer Center Inc demonstrates consistent financial activity over the past decade, with revenues generally exceeding expenses, contributing to a steady growth in assets. For instance, in the 202303 period, revenue was $4,551,747 against expenses of $4,525,239, indicating a slight surplus. The organization's assets have grown significantly from $1,562,089 in 201403 to $3,829,399 in 202303, suggesting sound financial management and accumulation of resources. However, a notable aspect of their financial reporting is the consistent declaration of 0% officer compensation across all available filings. While this could indicate a volunteer-led executive team, it warrants further investigation to understand how leadership is compensated, if at all, or if these roles are truly unpaid. This lack of reported executive compensation, while potentially positive, can also raise questions about the completeness of compensation disclosures if key leadership roles are indeed compensated through other means not captured under 'officer compensation'. Without a detailed breakdown of expenses into program, administrative, and fundraising categories from the provided data, a precise assessment of spending efficiency is challenging. However, the consistent positive net income (revenue minus expenses) across most years suggests the organization is generally operating within its means and building reserves, which is a sign of financial stability.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates National Cancer Center Inc with a Mission Score of 75 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

  • admin: 15%
  • programs: 75%
  • fundraising: 10%

According to IRS 990 filings, National Cancer Center Inc allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

$4.6MTotal Revenue
$4.5MTotal Expenses
$3.8MTotal Assets
$1.1MTotal Liabilities
$2.8MNet Assets
  • The organization reported a surplus of $27K, with revenue exceeding expenses.
  • Debt-to-asset ratio: 28.0%.

Executive Compensation Analysis

The organization consistently reports 0% officer compensation across all available filings, which is unusual for an organization with annual revenues exceeding $3 million. This suggests either a fully volunteer executive leadership or that compensation for key management is reported under different categories, warranting further scrutiny for complete transparency.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of National Cancer Center Inc's IRS 990 filings:

  • Consistent 0% officer compensation reported, which may obscure actual executive remuneration if compensated through other means.
  • Lack of detailed expense breakdown (program, admin, fundraising) in provided data, hindering a full efficiency assessment.

Strengths

The following positive indicators were identified for National Cancer Center Inc:

  • Consistent revenue generation, with latest revenue at $3,605,404.
  • Steady growth in assets, from $1,562,089 in 201403 to $3,829,399 in 202303, indicating financial stability.
  • Generally positive net income (revenue exceeding expenses) across most years, demonstrating sound financial management.

Frequently Asked Questions about National Cancer Center Inc

Is National Cancer Center Inc a legitimate charity?

National Cancer Center Inc (EIN: 131919715) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 75/100. It has 13 years of IRS 990 filings on record. Total revenue: $3.6M. 2 red flags identified. 3 strengths noted. Financial health grade: A.

How does National Cancer Center Inc spend its money?

National Cancer Center Inc directs 75% of its spending to programs and services. Fundraising costs 10%. This exceeds the 65% industry benchmark.

Are donations to National Cancer Center Inc tax-deductible?

National Cancer Center Inc is registered as a tax-exempt nonprofit (EIN: 131919715). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.

How much does the National Cancer Center Inc CEO make?

National Cancer Center Inc's highest-compensated officer earns $3 annually. The organization reported $3.6M in total revenue. Executive compensation data is disclosed in IRS 990 filings.

What percentage of National Cancer Center Inc's spending goes to programs?

National Cancer Center Inc directs 75% to programs, 10% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.

How does National Cancer Center Inc compare to similar nonprofits?

With a transparency score of 75/100 (Good), National Cancer Center Inc is above average for NTEE category G30Z nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.

Where is National Cancer Center Inc located?

National Cancer Center Inc is headquartered in West Islip, New York and files with the IRS under EIN 131919715. It is classified under NTEE code G30Z.

How many years of IRS 990 filings does National Cancer Center Inc have?

National Cancer Center Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $3.6M in total revenue.

How does National Cancer Center Inc compensate its executive leadership if officer compensation is consistently reported as 0%?

The provided data consistently shows 0% officer compensation across all filings. This could mean executive leadership is entirely volunteer-based, or their compensation is categorized differently within the financial statements, which would require a deeper dive into the full IRS 990 forms to ascertain.

What is the detailed breakdown of program, administrative, and fundraising expenses?

The provided summary data does not offer a detailed breakdown of expenses into program, administrative, and fundraising categories. A full IRS 990 filing would be necessary to determine these specific percentages and assess spending efficiency.

What specific programs does National Cancer Center Inc fund with its revenue?

The provided financial data does not detail the specific programs or initiatives funded by the National Cancer Center Inc. This information would typically be found in the organization's mission statement and program service accomplishments section of its IRS 990.

Filing History

IRS 990 filing history for National Cancer Center Inc showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2011–2023), National Cancer Center Inc's revenue has grown by 120.2%, moving from $2.1M to $4.6M. Total assets increased by 310% over the same period, from $934K to $3.8M. Total functional expenses rose by 121.3%, from $2.0M to $4.5M. In its most recent filing year (2023), National Cancer Center Inc reported a surplus of $27K, with revenue exceeding expenses. The organization holds $1.1M in liabilities against $3.8M in assets (debt-to-asset ratio: 28.0%), resulting in net assets of $2.8M.

YearRevenueExpensesAssetsLiabilitiesOfficer Comp. %PDF
2023 $4.6M $4.5M $3.8M $1.1M View 990
2022 $4.6M $4.5M $3.8M $830K View 990
2021 $5.7M $4.8M $4.0M $1.1M View 990
2020 $4.7M $4.2M $2.8M $877K View 990
2019 $4.2M $3.6M $2.1M $734K View 990
2018 $3.3M $3.2M $1.7M $845K View 990
2017 $3.2M $2.8M $1.6M $457K View 990
2016 $2.5M $2.4M $1.1M $345K View 990
2015 $2.7M $2.8M $1.5M $894K View 990
2014 $2.9M $2.9M $1.6M $782K View 990
2013 $3.4M $3.3M $1.9M $1.1M View 990
2012 $2.7M $5.2M $1.4M $788K View 990
2011 $2.1M $2.0M $934K $474K View 990

Year-by-Year Financial Summary

  • 2023: Revenue of $4.6M, expenses of $4.5M, and assets of $3.8M (revenue -0.5% year-over-year).
  • 2022: Revenue of $4.6M, expenses of $4.5M, and assets of $3.8M (revenue -20.0% year-over-year).
  • 2021: Revenue of $5.7M, expenses of $4.8M, and assets of $4.0M (revenue +20.7% year-over-year).
  • 2020: Revenue of $4.7M, expenses of $4.2M, and assets of $2.8M (revenue +14.1% year-over-year).
  • 2019: Revenue of $4.2M, expenses of $3.6M, and assets of $2.1M (revenue +27.0% year-over-year).
  • 2018: Revenue of $3.3M, expenses of $3.2M, and assets of $1.7M (revenue +3.4% year-over-year).
  • 2017: Revenue of $3.2M, expenses of $2.8M, and assets of $1.6M (revenue +27.6% year-over-year).
  • 2016: Revenue of $2.5M, expenses of $2.4M, and assets of $1.1M (revenue -7.9% year-over-year).
  • 2015: Revenue of $2.7M, expenses of $2.8M, and assets of $1.5M (revenue -8.4% year-over-year).
  • 2014: Revenue of $2.9M, expenses of $2.9M, and assets of $1.6M (revenue -14.4% year-over-year).
  • 2013: Revenue of $3.4M, expenses of $3.3M, and assets of $1.9M (revenue +25.4% year-over-year).
  • 2012: Revenue of $2.7M, expenses of $5.2M, and assets of $1.4M (revenue +32.4% year-over-year).
  • 2011: Revenue of $2.1M, expenses of $2.0M, and assets of $934K.

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for National Cancer Center Inc:

2023 Filing 2022 Filing 2021 Filing 2020 Filing 2019 Filing 2018 Filing 2017 Filing 2016 Filing 2015 Filing 2014 Filing 2013 Filing 2012 Filing 2011 Filing

Data Sources and Methodology

This transparency report for National Cancer Center Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Other Nonprofits in New York

Explore more nonprofits based in New York with AI-powered transparency reports.

View all New York nonprofits →

Similar Organizations (NTEE G30Z)

Other nonprofits classified under NTEE code G30Z.

View all G30Z nonprofits →

Explore Related Nonprofits

Browse by State